Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Benzylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120271403A reveals a novel nickel-photocatalytic route for chiral benzylamine. This method offers mild conditions and significant supply chain cost reduction.
Novel synthesis method avoids extreme cold conditions ensuring high purity pharmaceutical intermediates supply chain stability and cost efficiency.
Advanced synthesis of 2-methoxy-4-methylbenzylamine via safe reductive amination. Offers significant cost reduction in fine chemical manufacturing and high purity.
Patent CN109320434A reveals ionic iron catalysts for benzylamine synthesis offering green chemistry advantages and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110305025B details a green photocatalytic method for benzylamine synthesis using Eosin Y and water, offering significant cost and safety advantages for pharmaceutical intermediates.
Patent CN117326973B enables green room temperature oxidation. Low cost heavy metal free process ensures supply chain stability for pharma intermediates.
Solve low yield & high cost in fexuprazan intermediate production. New route with >50% yield, 50% cost reduction. Scale to 100MT/yr.
Eliminate NaN3 hazards in DL-α-aminocaprolactam production. This two-step method offers high yields (81-85%) and simplified purification, reducing supply chain risks for lysine manufacturing.